IL28B GENETIC STATUS IN ASSOCIATION WITH HCV SPECIFIC T-CELL IMMUNITY

IL28B GENETIC STATUS IN ASSOCIATION WITH HCV SPECIFIC T-CELL IMMUNITY

Bibliografiske detaljer
Main Authors:	Bucci, C, Rahman, M, Humphreys, I, Brown, A, Lucas, M, Pfafferott, K, Collier, J, O'Donnell, D, Stafford, E, Klenerman, P, Gaudieri, S, Barnes, E
Format:	Conference item
Udgivet:	2011

Lignende værker

Full-length sequence analysis of HCV genotype-3A reveals novel regions of hypervariability
af: Humphreys, I, et al.
Udgivet: (2007)

MULTIPLE NOVEL PEPTIDE EPITOPES IN HCV GENOTYPE-3A IDENTIFIED USING TWO PARALLEL APPROACHES
af: Boehmer, A, et al.
Udgivet: (2011)

The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design.
af: von Delft, A, et al.
Udgivet: (2015)

Immune responses in acute and chronic HCV genotype 3a infection detected by two distinct techniques
af: von Delft, A, et al.
Udgivet: (2011)

HCV genotype-3a T cell immunity: specificity, function and impact of therapy
af: Humphreys, IS, et al.
Udgivet: (2012)

HCV genotype-3a T cell immunity: Specificity, function and impact of therapy
af: Humphreys, I, et al.
Udgivet: (2012)

HCV genotype-3a T cell immunity: specificity, function and impact of therapy.
af: Humphreys, I, et al.
Udgivet: (2012)

Constrained pattern of viral evolution in acute and early HCV infection limits viral plasticity.
af: Pfafferott, K, et al.
Udgivet: (2011)

A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
af: Kelly, C, et al.
Udgivet: (2011)

Constrained pattern of viral evolution in acute and early HCV infection limits viral plasticity.
af: Katja Pfafferott, et al.
Udgivet: (2011-02-01)

IN VIVO ANTIGENIC TARGETS OF T CELLS INDUCED BY ADENOVIRAL VECTORED VACCINES IN PATIENTS WITH CHRONIC HCV INFECTION
af: Kelly, C, et al.
Udgivet: (2012)

High dose interferon-alpha induction therapy is associated with a profound loss of IL-2 and IFN-gamma secreting HCV specific T-cells
af: Gelderblom, H, et al.
Udgivet: (2007)

Full-length characterization of hepatitis C virus subtype 3a reveals novel hypervariable regions under positive selection during acute infection
af: Humphreys, I, et al.
Udgivet: (2009)

Full-length characterization of hepatitis C virus subtype 3a reveals novel hypervariable regions under positive selection during acute infection (Journal of Virology (2009) 83, 22 (11456-11466))
af: Humphreys, I, et al.
Udgivet: (2010)

Full-length characterization of hepatitis C virus subtype 3a reveals novel hypervariable regions under positive selection during acute infection.
af: Humphreys, I, et al.
Udgivet: (2009)

Full-Length Characterization of Hepatitis C Virus Subtype 3a Reveals Novel Hypervariable Regions under Positive Selection during Acute Infection (vol 83, pg 11456, 2009)
af: Humphreys, I, et al.
Udgivet: (2010)

HCV immunology--death and the maiden T cell.
af: Willberg, C, et al.
Udgivet: (2003)

Ever closer to a prophylactic vaccine for HCV.
af: Swadling, L, et al.
Udgivet: (2013)

Influence of HIV and HCV on T cell antigen presentation and challenges in the development of vaccines
af: Mina eJohn, et al.
Udgivet: (2014-10-01)

EPSTI1 Is Involved in IL-28A-Mediated Inhibition of HCV Infection
af: Xianghe Meng, et al.
Udgivet: (2015-01-01)

Tryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism
af: Heinz Zoller, et al.
Udgivet: (2015-06-01)

Genetic variations in IL28B and allergic disease in children.
af: Silvana Gaudieri, et al.
Udgivet: (2012-01-01)

HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.
af: Sonya A MacParland, et al.
Udgivet: (2016-01-01)

The global distribution and prevalence of HCV genotypes
af: Messina, J, et al.
Udgivet: (2014)

HCV-specific T-CELL responses of acutely HCV infected individuals with and without HIV.
af: Danta, M, et al.
Udgivet: (2005)

Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection.
af: Semmo, N, et al.
Udgivet: (2005)

Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy.
af: Rohrbach, J, et al.
Udgivet: (2010)

Comparison of IL-28B favorable genotype frequency between healthy and patients infected with HCV
af: Javad Moayedi, et al.
Udgivet: (2018-06-01)

A pan-genotype HCV T cell vaccine, in a simian adenovirus vector, to target T cell epitopes conserved across multiple HCV genotypes
af: Donnison, T, et al.
Udgivet: (2018)

Pharmacogenetics of efficacy and safety of HCV treatment in HCV-HIV coinfected patients: significant associations with IL28B and SOCS3 gene variants.
af: Francesc Vidal, et al.
Udgivet: (2012-01-01)

'Favourable' IL28B polymorphisms are associated with a marked increase in baseline viral load in hepatitis C virus subtype 3a infection and do not predict a sustained virological response after 24 weeks of therapy.
af: Bucci, C, et al.
Udgivet: (2013)

The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes
af: von Delft, A, et al.
Udgivet: (2017)

Hepatitis C virus (HCV) cellular immune responses are induced during combination therapy but are not sustained.
af: Barnes, E, et al.
Udgivet: (2000)

Relationship between gene polymorphism of IL-28B and clinical, laboratory, virologic parameters in patients with chronic HCV-infection
af: K. V. Zhdanov, et al.
Udgivet: (2014-12-01)

Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients
af: Ghada M. Salum, et al.
Udgivet: (2020-09-01)

Hepatitis C Virus (HCV) diagnosis and access to treatment in a UK cohort
af: Adland, E, et al.
Udgivet: (2018)

Polymorphism of Interleukin 28 and HCV: Implementation of a method
af: Alessandra Flaminio, et al.
Udgivet: (2012-12-01)

Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes.
af: Harcourt, G, et al.
Udgivet: (2004)

Methodologies for the analysis of HCV-specific CD4+ T cells
af: Megha eLokhande, et al.
Udgivet: (2015-02-01)

Methodologies for the analysis of HCV-specific CD4(+) T cells
af: Lokhande, M, et al.
Udgivet: (2015)